(Q34398488)

English

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

decision making

1 reference

based on heuristic

inferred from title

3

object named as

Saad Shakir

0 references

author name string

Rhian McNaughton

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gwenaël Huet

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Saad Shakir

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

15 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

e004221

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902466

6 July 2018

Methodological and political issues in clinical pharmacology research by the year 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902466

6 July 2018

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902466

27 October 2018

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902466

27 October 2018

Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24435895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/24435895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJOPEN-2013-004221

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34398488&oldid=1962848254"